Applied Finance Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Applied Finance Capital Management's BMY Position: Q2 2026 in Review
Applied Finance Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 35,950 shares worth $2.07M. The stake represents 0.15% of the portfolio and ranks #71 among its holdings. This is a return to the name: Applied Finance Capital Management previously reported a position in BMY as recently as Q1 2025.
Applied Finance Capital Management first reported a position in BMY in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.34M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Applied Finance Capital Management held 35,950 shares of Bristol-Myers Squibb worth $2.07M as of Q2 2026.
- Bristol-Myers Squibb was a new Applied Finance Capital Management position in Q2 2026.
- Bristol-Myers Squibb made up 0.15% of Applied Finance Capital Management's portfolio in Q2 2026, its #71 holding.
- Applied Finance Capital Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 5 quarters since.
- Applied Finance Capital Management's Bristol-Myers Squibb position peaked at $2.34M in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.